[{"indications": "Indications\u00a0see under Dose", "name": "DISODIUM ETIDRONATE With calcium carbonate", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "DISODIUM ETIDRONATE", "With calcium carbonate"], "cautions": "Cautions\u00a0consider dental check-up before initiating\r\nbisphosphonate (risk of osteonecrosis of\r\nthe jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0nausea, diarrhoea or constipation, abdominal pain,\r\nincreased bone pain in Paget\u2019s disease, also increased risk of fractures\r\nwith high doses in Paget\u2019s disease (discontinue if fractures occur); rarely exacerbation of asthma, skin reactions (including\r\nangioedema, rash, urticaria and pruritus), transient hyperphosphataemia,\r\nheadache, paraesthesia, peripheral neuropathy, atypical femoral fractures\r\n(see MHRA/CHM advice); very rarely osteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw);\r\nblood disorders (including leucopenia, agranulocytosis and pancytopenia)\r\nalso reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4451.htm", "doses": ["Paget\u2019s disease of bone, by mouth, 5\u00a0mg/kg\r\nas a single daily dose for up to 6 months; doses above 10\u00a0mg/kg daily\r\nfor up to 3 months may be used with caution but doses above 20\u00a0mg/kg\r\ndaily are not recommended; after interval of not less than 3 months\r\nmay be repeated where evidence of reactivation\u2014including biochemical\r\nindices (avoid premature retreatment)", "Serum phosphate, serum alkaline phosphatase\r\nand (if possible) urinary hydroxyproline should be measured before\r\nstarting and at intervals of 3 months\u2014consult product literature for\r\nfurther details", "Osteoporosis, see under Didronel PMO\u00ae", "Avoid food for at least 2 hours before\r\nand after oral treatment, particularly calcium-containing products\r\ne.g. milk; also avoid iron and mineral supplements and antacids", "Name[Didronel PMO\u00ae (Warner Chilcott) ] Tablets, 14 white, disodium\r\netidronate 400\u00a0mg; 76 pink, effervescent, calcium carbonate\r\n1.25\u00a0g (Cacit\u00ae). Net price per pack = \u00a319.89. \r\n    Label:\r\n    10, patient information leaflet, counselling, food and calcium (see above)Dose\u00a0treatment of osteoporosis, prevention of bone loss in\r\npostmenopausal women (particularly if hormone replacement therapy\r\ninappropriate), and prevention and treatment of corticosteroid-induced\r\nosteoporosis, given in 90-day cycles, 1 Didronel\u00ae tablet daily for 14 days, then 1 Cacit\u00ae tablet\r\ndaily for 76 days"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see under Dose", "name": "DISODIUM ETIDRONATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "DISODIUM ETIDRONATE"], "cautions": "Cautions\u00a0consider dental check-up before initiating\r\nbisphosphonate (risk of osteonecrosis of\r\nthe jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0nausea, diarrhoea or constipation, abdominal pain,\r\nincreased bone pain in Paget\u2019s disease, also increased risk of fractures\r\nwith high doses in Paget\u2019s disease (discontinue if fractures occur); rarely exacerbation of asthma, skin reactions (including\r\nangioedema, rash, urticaria and pruritus), transient hyperphosphataemia,\r\nheadache, paraesthesia, peripheral neuropathy, atypical femoral fractures\r\n(see MHRA/CHM advice); very rarely osteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw);\r\nblood disorders (including leucopenia, agranulocytosis and pancytopenia)\r\nalso reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/12505.htm", "doses": ["Paget\u2019s disease of bone, by mouth, 5\u00a0mg/kg\r\nas a single daily dose for up to 6 months; doses above 10\u00a0mg/kg daily\r\nfor up to 3 months may be used with caution but doses above 20\u00a0mg/kg\r\ndaily are not recommended; after interval of not less than 3 months\r\nmay be repeated where evidence of reactivation\u2014including biochemical\r\nindices (avoid premature retreatment)", "Serum phosphate, serum alkaline phosphatase\r\nand (if possible) urinary hydroxyproline should be measured before\r\nstarting and at intervals of 3 months\u2014consult product literature for\r\nfurther details", "Osteoporosis, see under Didronel PMO\u00ae", "Avoid food for at least 2 hours before\r\nand after oral treatment, particularly calcium-containing products\r\ne.g. milk; also avoid iron and mineral supplements and antacids"], "pregnancy": "Pregnancy\u00a0avoid"}]